Design, synthesis, and structure–activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents

Anna‐Maria Monforte; Patrizia Logoteta; Stefania Ferro; Laura De Luca; Nunzio Iraci; Giovanni Maga; De Clercq Erik; Christophe Pannecouque; Alba Chimirri

doi:10.1016/j.bmc.2009.06.068

Back

Design, synthesis, and structure–activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents

Article 2009 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2002

Design, Synthesis, Structure−Activity Relationships, and Molecular Modeling Studies of 2,3-Diaryl-1,3-thiazolidin-4-ones as Potent Anti-HIV Agents

Maria Letizia Barreca, Jan Balzarini, Alba Chimirri, De Clercq Erik, Laura De Luca, Hans Dieter Höltje, Monika Höltje, Anna Maria Monforte, Pietro Monforte, Christophe Pannecouque, Angela Rao, Maria Zappalà

Article2007

Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents

Ravindra K. Rawal, Rajkamal Tripathi, S. B. Katti, Christophe Pannecouque, De Clercq Erik

Article2007

Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

Ravindra K. Rawal, Rajkamal Tripathi, S. B. Katti, Christophe Pannecouque, De Clercq Erik

Article2006

Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

Ravindra K. Rawal, Rajkamal Tripathi, S. B. Katti, Christophe Pannecouque, De Clercq Erik

Article1993

2',3'-Dideoxynucleoside analogues as anti-HIV agents

Piet Herdewijn, Jan Balzarini, De Clercq Erik